Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma
- 1 December 2009
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 78 (11), 1374-1381
- https://doi.org/10.1016/j.bcp.2009.07.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Sanguinarine‐induced apoptosis: Generation of ROS, down‐regulation of Bcl‐2, c‐FLIP, and synergy with TRAILJournal of Cellular Biochemistry, 2008
- The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarineCell Biology and Toxicology, 2006
- Strategies for the Development of More Effective Adjuvant Therapy of Melanoma: Current and Future Explorations of Antibodies, Cytokines, Vaccines, and CombinationsClinical Cancer Research, 2006
- Cutaneous melanoma: available therapy for metastatic diseaseDermatologic Therapy, 2006
- Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary glandMenopause, 2006
- The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanomaFrontiers in Bioscience-Landmark, 2005
- Suppression of angiogenesis by the plant alkaloid, sanguinarineBiochemical and Biophysical Research Communications, 2004
- Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nucleiBiochemistry, 1985
- Sanguinarine: a monofunctional intercalating alkaloidFEBS Letters, 1982